- Home
- QNTM vs PAVM Comparison
QNTM vs PAVM Comparison
Compare QNTM & PAVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QNTM
- PAVM
- Stock Information
- Founded
- QNTM 1998
- PAVM 2014
- Country
- QNTM Canada
- PAVM United States
- Employees
- QNTM N/A
- PAVM N/A
- Industry
- QNTM
- PAVM Medical/Dental Instruments
- Sector
- QNTM
- PAVM Health Care
- Exchange
- QNTM NYSE
- PAVM Nasdaq
- Market Cap
- QNTM 9.1M
- PAVM 10.2M
- IPO Year
- QNTM N/A
- PAVM 2016
- Fundamental
- Price
- QNTM $5.10
- PAVM $1.01
- Analyst Decision
- QNTM
- PAVM Strong Buy
- Analyst Count
- QNTM 0
- PAVM 1
- Target Price
- QNTM N/A
- PAVM $21.00
- AVG Volume (30 Days)
- QNTM 66.2K
- PAVM 52.5K
- Earning Date
- QNTM 11-12-2024
- PAVM 11-13-2024
- Dividend Yield
- QNTM N/A
- PAVM N/A
- EPS Growth
- QNTM N/A
- PAVM N/A
- EPS
- QNTM N/A
- PAVM 0.53
- Revenue
- QNTM N/A
- PAVM $4,034,000.00
- Revenue This Year
- QNTM N/A
- PAVM $70.80
- Revenue Next Year
- QNTM N/A
- PAVM $298.02
- P/E Ratio
- QNTM N/A
- PAVM $1.95
- Revenue Growth
- QNTM N/A
- PAVM 166.27
- 52 Week Low
- QNTM $3.50
- PAVM $0.60
- 52 Week High
- QNTM $96.20
- PAVM $4.88
- Technical
- Relative Strength Index (RSI)
- QNTM 49.64
- PAVM 43.42
- Support Level
- QNTM $4.75
- PAVM $0.99
- Resistance Level
- QNTM $5.35
- PAVM $1.10
- Average True Range (ATR)
- QNTM 0.45
- PAVM 0.09
- MACD
- QNTM -0.04
- PAVM -0.00
- Stochastic Oscillator
- QNTM 32.64
- PAVM 9.09
About QNTM QUANTUM BIOPHARMA LTD
Quantum BioPharma Ltd formerly FSD Pharma Inc is a biopharmaceutical company developing three clinical candidates with the potential to address neuropsychiatric, neurodegenerative, and inflammatory disorders. Along with its subsidiaries, the group is focused on pharmaceutical research and development of its compound, FSD201, an ultra-micronized PEA, for the treatment of inflammatory diseases; Lucid-Psych is used in the treatment of mental health disorders and Lucid-MS is used in the treatment of neurodegenerative disorders. The company operates in two segments: Biopharmaceutical and Strategic Investments.
About PAVM PAVmed Inc.
PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The Company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, esocheck, and the Veris Cancer Care Platform.